I have only taken a couple of casual looks at ACL over the years, but I would rather buy and hold the out-and-out market leader with the track record to match for long periods.
Unless ACL is at a can’t-refuse kind of valuation, or SHL is egregiously valued (which it is not - kind of middle-of-the-road), sticking with the industry top dog is the way to go generally.
Ann: Half Yearly Report and Accounts, page-25
Add SHL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$26.76 |
Change
0.160(0.60%) |
Mkt cap ! $12.85B | |||
| Open | High | Low | Value | Volume |
| $26.58 | $26.76 | $26.43 | $26.90M | 1.008M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 449 | $26.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $26.76 | 5727 | 2 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$26.72 |
Change
0.160 ( 0.59 %) |
||||
| Open | High | Low | Volume | ||
| $26.49 | $26.74 | $26.43 | 93535 | ||
| Last updated 15.59pm 10/05/2024 ? | |||||
| SHL (ASX) Chart |